StockData
Annovis Bio, Inc. logo

Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.74−0.01 (-0.91%)

Close on Nov 17, 2026Market cap $31.66MP/E –Yield –

Annovis Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Annovis Bio's price to book ratio was 16.0× on Jul 31, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.7× to 136.1×, with a median of 4.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202616.0×+10.7
2025Dec 31, 20255.3×−4.1
2024Dec 31, 20249.5×−15.9
2023Dec 29, 202325.3×+22.1
2022Dec 30, 20223.2×+0.1
2021Dec 31, 20213.1×−2.6
2020Dec 31, 20205.7×–

More Annovis Bio figures

See a number that looks wrong?